Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV. (Q42983710)
Jump to navigation
Jump to search
scientific article published on 25 August 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV. |
scientific article published on 25 August 2012 |
Statements
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV (English)
Marco Massari
Simona Urbani
Tiziana Giuberti
Caterina Valdatta
Albertina Cavalli
25 August 2012